Skip to main content
Premium Trial:

Request an Annual Quote

Measles, Mumps, Multiple Myeloma

Premium

While most cancer vaccines are intended to fight cancers that have already developed, Massachusetts-based biotech start-up OncoPep is working on a vaccine designed to prevent multiple myeloma before it even starts, says Technology Review's Courtney Humphries. The vaccine is meant for patients who have precursors of the blood cancer in their cells — it contains a combination of peptides that are specific to multiple myeloma in order to "train the immune system to recognize and attack cancer cells bearing these peptides," Humphries says. The company hopes that detecting the cancer in the early stages could lead to effective early intervention, and that vaccines like this one could help patients while their own immune systems are still healthy.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.